Skip to main content
SJRES 22 110th Congress Senate Health Administrative procedure Blood Cancer Congress Congressional veto Department of Health and Human Services Government Operations and Politics Law Medicare Social Welfare

A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Introduced: October 22, 2007 See on congress.gov
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 22, 2007
Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S13201-13202)
Oct 22, 2007
Sponsor introductory remarks on measure. (CR S13200-13201)
Oct 22, 2007
Introduced in Senate
 Plain-English summary Congressional Research Service

Disapproves a specified rule submitted by the Centers for Medicare & Medicaid Services of the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.

Declares that such rule shall have no force or effect.

What's happening now October 22, 2007

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S13201-13202)

 Committees of jurisdiction 1